STASKA Pharmaceuticals

What STASKA Pharmaceuticals does

STASKA Pharmaceuticals is an FDA-registered 503B outsourcing facility headquartered at 742 Evergreen Dr, Bennet, Nebraska, specializing in the manufacture of customized sterile and non-sterile compounded pharmaceuticals for healthcare providers. The company serves surgery centers, hospitals, and medical offices across Nebraska and surrounding areas, offering preservative-free single-use injectables, preserved multi-dose vials, specialty unit-dose syringes, and bespoke compounding services. Its product catalog includes ascorbic acid, glutathione, buffered lidocaine, B-complex, methylcobalamin, hydroxocobalamin, and upcoming launches of dexpanthenol and vitamin D injections.

Operationally, STASKA runs a 7,300 sq ft cGMP-certified manufacturing facility featuring a 3,000 sq ft cleanroom suite, a 1,200 sq ft ISO 7 classified room, and four ISO 5 laminar flow hoods for aseptic processing. The facility includes in-house chemical (potency and impurities) and microbiological (BET and MLT) testing capabilities and operates under a three-step quality management system emphasizing right-first-time execution, risk-based manufacturing, and operational transparency. The company holds FDA 503B registration (the only one in Nebraska), cGMP certification, and LegitScript certification (08/23/2024).

Commercially, STASKA operates a B2B, field-sales-driven model with consultation-based customer engagement, no public pricing, and direct distribution to healthcare facility decision-makers. The company is privately held and founder-operated by CEO Lyndon Leitner, PharmD, who brings 20 years of pharmaceutical experience including prior ownership of National Pharmacy in Lincoln, NE and district management of 31 Kmart Pharmacies across four states. As of the available data, STASKA has no disclosed funding rounds, no institutional investors, and no reported revenue figures, consistent with its positioning as an early-stage, founder-led 503B outsourcing startup.

Name

STASKA Pharmaceuticals

Legal name

STASKA Pharmaceuticals

Website

https://staskapharma.com

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

11–50 employees

Short description

STASKA Pharmaceuticals is an FDA-registered 503B outsourcing facility in Bennet, Nebraska that manufactures customized sterile and non-sterile compounded pharmaceuticals for surgery centers, hospitals, and medical offices across Nebraska and surrounding areas.

Ownership category

akta.pro rank

Product category

Compounded Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Contract Development & Manufacturing for Generics (CDMO/CMO) (HLAIABAI)

akta.pro secondary industry

Compounding Pharmacies (Sterile/Non-Sterile) (HLAFALAE)

Keywords

• 503B outsourcing facility
• Compounded pharmaceuticals
• Sterile injectables
• Custom compounding services
• Pharmaceutical manufacturing

Headquarters

HQ city

Bennet

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Compounded Pharmaceutical Products: STASKA generates revenue through the manufacture and sale of customized sterile and non-sterile compounded pharmaceutical products to healthcare providers including surgery centers, hospitals, and medical offices. Products include preservative-free and preserved formulations in various dosages and delivery formats.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

STASKA Pharmaceuticals is an FDA registered 503B outsourcing facility that manufactures and supplies customized sterile and non-sterile compounded pharmaceutical products to healthcare providers. The company operates a cGMP-certified manufacturing facility in Bennet, Nebraska, with ISO 7 cleanroom and ISO 5 laminar flow hood capabilities, producing preservative-free single-use injectables, preserved multi-dose vials, and bespoke compounded formulations for surgery centers, hospitals, and medical offices.

Product overview

STASKA Pharmaceuticals operates as an FDA-registered 503B outsourcing facility offering a portfolio of compounded pharmaceuticals divided into three tiers: (1) Current Products including preservative-free single-use injectables (Ascorbic Acid, Glutathione, Buffered Lidocaine) and preserved multi-dose vials (Glutathione, B-Complex, Methylcobalamin at two concentrations); (2) Specialty Products by Request featuring custom unit dose syringes in various formulations and concentrations; and (3) a custom compounding service for healthcare providers requiring bespoke sterile and non-sterile formulations. The company provides both sterile and non-sterile product lines delivered to surgery centers, hospitals, and medical offices.

Differentiator

Problem solved

Functional benefit

Products and services

• Custom Compounding Services Custom pharmaceutical compounding services providing customized sterile and non-sterile products to healthcare providers including surgery centers, hospitals, and medical offices.
• Ascorbic Acid 500mg/ml (Non-Corn) 50ml Vial Preservative-free single-use vitamin C injection in a 50ml vial, formulated without corn derivatives.
• Glutathione 200mg/ml 10ml Vial Preservative-free single-use antioxidant injection in a 10ml vial.
• Buffered Lidocaine HCL 2% (20mg/ml) 10ml Unit Dose Syringe Preservative-free single-use local anesthetic in pre-filled 10ml unit dose syringe.
• Buffered Lidocaine HCL 2% (20mg/ml) 50ml Vial Preservative-free single-use local anesthetic in a 50ml vial.
• Glutathione 200mg/ml 30ml Vial Multi-dose preserved antioxidant injection in a 30ml vial.
• B-Complex 30ml Vial Multi-dose preserved B vitamin complex injection in a 30ml vial.
• Methylcobalamin 1mg/ml 30ml Vial Multi-dose preserved vitamin B12 injection at 1mg/ml concentration in a 30ml vial.
• Methylcobalamin 5mg/ml 30ml Vial Multi-dose preserved vitamin B12 injection at 5mg/ml concentration in a 30ml vial.
• Ascorbic Acid 500mg/ml (Non-Corn) Preservative Free 10ml Single Use Syringe Specialty single-use vitamin C injection in pre-filled 10ml syringe, formulated without corn derivatives.
• Methylcobalamin 1mg/ml Preservative Free 1ml Unit Dose Syringe Specialty single-use vitamin B12 injection at 1mg/ml concentration in pre-filled 1ml unit dose syringe.
• Hydroxocobalamin 2mg/ml Preservative Free 1ml Unit Dose Syringe Specialty single-use vitamin B12 (hydroxocobalamin) injection at 2mg/ml concentration in pre-filled 1ml unit dose syringe.
• Buffered Lidocaine 1% (10mg/ml) Preservative Free 10ml Unit Dose Syringe Specialty single-use local anesthetic at 1% concentration in pre-filled 10ml unit dose syringe, available in 'No-Sting' formulation.
• Lidocaine 1% / Epinephrine 1:100,000 Preservative Free 5ml Unit Dose Syringe Specialty single-use local anesthetic with vasoconstrictor in pre-filled 5ml unit dose syringe.

Quantifiable outcome

• All processes and procedures documented and executed with precision
• +1 more outcomes

Named customers3 records

Segments2 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• US FCRminorOthersUS FCR 2025 certification partner. STASKA displays US FCR certification badge on website footer indicating participation in FDA verification and compliance reporting program.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Wells Pharma of Houston: Wells Pharma is an FDA-registered 503B outsourcing facility producing sterile compounded preparations. Comparable to STASKA as a regional 503B peer in sterile injectable outsourcing with a similar product/customer profile.
• US Compounding: US Compounding is an FDA-registered 503B outsourcing facility producing sterile compounded preparations. Comparable to STASKA as a 503B outsourcing peer in sterile injectable manufacturing for hospital and provider customers.
• Olympia Pharmaceuticals: Olympia Pharmaceuticals operates as an FDA-registered 503B outsourcing facility offering sterile and non-sterile compounded preparations. Comparable to STASKA in regulatory standing, product category, and healthcare provider customer base, though with broader national reach.
• Leiters Health: Leiters Health is an FDA-registered 503B outsourcing facility focused on sterile injectable outsourcing for hospital and health system customers. Comparable to STASKA in product category (sterile injectables), regulatory classification, and provider-targeting GTM.
• PharMEDium Services (AmerisourceBergen): PharMEDium is a major 503B outsourcing facility (now owned by AmerisourceBergen) supplying sterile compounded preparations to hospitals nationwide. Comparable to STASKA as a 503B peer in sterile admixture services, with materially larger scale and broader formulary.
• QuVa Pharma: QuVa Pharma is one of the largest FDA-registered 503B outsourcing facilities in the U.S., producing sterile compounded injectables for hospitals and surgery centers. Directly comparable to STASKA in regulatory pathway, product category (sterile injectables), and customer base, but with national multi-site scale.
• SCA Pharmaceuticals: SCA Pharmaceuticals is an FDA-registered 503B outsourcing facility producing sterile injectable preparations for hospital pharmacies. Direct peer to STASKA in compounding services, cGMP infrastructure, and B2B healthcare provider GTM.

Emerging players

• Empower Pharmacy: Empower Pharmacy is a 503A compounding pharmacy with growing 503B operations, producing sterile and non-sterile preparations. Comparable to STASKA in compounding activity and customer base, though operates primarily under 503A pathways.

Broad incumbents

• Central Admixture Pharmacy Services (CAPS): CAPS is the largest network of FDA-registered 503B outsourcing facilities in the U.S., part of B. Braun. Comparable to STASKA as a 503B peer in sterile admixture outsourcing, but operates nationally with substantially broader product portfolio and parent-company capital backing.
• Fagron North America: Fagron is a global leader in pharmaceutical compounding, supplying APIs, bases, and sterile/non-sterile compounding services. Comparable to STASKA as a peer in the compounding services space, though Fagron operates much more broadly as an ingredient supplier and outsourcing provider.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/staska-pharmaceuticals

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about STASKA Pharmaceuticals